Clinical Trial Update: Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients. [Phase 2]

View source ↗

Summary

Investigator-initiated Phase II trial of DSP-7888 cancer vaccine in patients with Acute Myeloid Leukemia in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia in Remission

Drugs mentioned

• DSP-7888

Snippet

Sponsor: Osaka University | Conditions: Acute Myeloid Leukemia in Remission | Phase 2 | Status: UNKNOWN